SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27540 |
Resumo: | Introduction: Respiratory viruses are often responsible for pulmonary exacerbations and increased morbimortality in patients with cystic fibrosis (CF). For this reason, SARS-CoV-2 was expected to have a significant impact on the respiratory status of these patients, especially in those at risk. Detailed data of the clinical course of COVID-19 in children with CF is scarce. Objectives: The aim of this study was to determine the incidence, clinical characteristics, and course of COVID-19 infection in pediatric patients with CF. Material and methods: This was a retrospective observational study of children with CF and SARS-CoV-2 infection followed at a Portuguese reference centre between March 2020 and March 2022. Results: Twelve of 30 children with CF were infected by SARS-CoV-2 (40%), in a total of 13 episodes. The median age was 10.5 years, and 33% were male. Most cases (69%) occurred between January and March 2022, when Omicron was the predominant variant. The infection rate was higher in children not fully vaccinated. None of the children with additional risk factors was infected. Ninety-two percent of patients presented with mild disease and one child with low body mass index was hospitalized with pneumonia. None required oxygen therapy or admission to the Intensive Care Unit. No cases of mortality were reported. Eighty-three percent of patients fully recovered after two months of follow-up. Discussion: In this first national study of children with CF and COVID-19 infection, most children presented with mild disease and could be safely managed at home. Conclusion: This study is in line with the few evidence available in the literature and contributes to a better understanding of SARS-CoV-2 infection in children with CF during predominance of the Omicron variant, providing additional data that can guide families and clinical teams in the management of patients. |
id |
RCAP_c5e27ca3bfadc6ce4074d5ba2df74e6b |
---|---|
oai_identifier_str |
oai:ojs.revistas.rcaap.pt:article/27540 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centreInfeção por SARS-CoV-2 em crianças com fibrose quística: Experiência de um centro de referência portuguêsOriginal ArticlesIntroduction: Respiratory viruses are often responsible for pulmonary exacerbations and increased morbimortality in patients with cystic fibrosis (CF). For this reason, SARS-CoV-2 was expected to have a significant impact on the respiratory status of these patients, especially in those at risk. Detailed data of the clinical course of COVID-19 in children with CF is scarce. Objectives: The aim of this study was to determine the incidence, clinical characteristics, and course of COVID-19 infection in pediatric patients with CF. Material and methods: This was a retrospective observational study of children with CF and SARS-CoV-2 infection followed at a Portuguese reference centre between March 2020 and March 2022. Results: Twelve of 30 children with CF were infected by SARS-CoV-2 (40%), in a total of 13 episodes. The median age was 10.5 years, and 33% were male. Most cases (69%) occurred between January and March 2022, when Omicron was the predominant variant. The infection rate was higher in children not fully vaccinated. None of the children with additional risk factors was infected. Ninety-two percent of patients presented with mild disease and one child with low body mass index was hospitalized with pneumonia. None required oxygen therapy or admission to the Intensive Care Unit. No cases of mortality were reported. Eighty-three percent of patients fully recovered after two months of follow-up. Discussion: In this first national study of children with CF and COVID-19 infection, most children presented with mild disease and could be safely managed at home. Conclusion: This study is in line with the few evidence available in the literature and contributes to a better understanding of SARS-CoV-2 infection in children with CF during predominance of the Omicron variant, providing additional data that can guide families and clinical teams in the management of patients.Introdução: Dado que os vírus são frequentemente responsáveis por exacerbações respiratórias e aumento da morbimortalidade em doentes com fibrose quística (FQ), seria expetável que a infeção por SARS-CoV-2 tivesse um impacto significativo na condição respiratória destes doentes, sobretudo nos de risco elevado. Atualmente, o conhecimento acerca da evolução clínica da COVID-19 em crianças com FQ é escasso. Objetivo: O objetivo deste estudo foi avaliar a incidência, apresentação clínica e evolução da COVID-19 em doentes pediátricos com FQ. Materiais e Métodos: Este foi um estudo retrospetivo de crianças com FQ e infeção por SARS-CoV-2 seguidas num centro de referência português entre março de 2020 e março de 2022. Resultados: Doze de 30 crianças com FQ foram infetadas por SARS-CoV-2 (40%), num total de 13 episódios. A mediana de idades foi de 10.5 anos e 33% eram rapazes. A maioria dos casos (69%) ocorreu entre janeiro e março de 2022, durante a predominância da variante Omicron. A taxa de infeção foi superior em crianças com vacinação incompleta. Nenhum dos doentes com fatores de risco adicionais foi infetado. Noventa e dois por cento das crianças apresentaram doença ligeira e um adolescente com baixo índice de massa corporal foi hospitalizado por pneumonia. Nenhum necessitou de oxigenoterapia ou internamento em Unidade de Cuidados Intensivos. A mortalidade foi nula. Oitenta e três porcento dos doentes apresentou recuperação completa após dois meses de seguimento. Discussão: Neste primeiro estudo nacional de crianças com FQ e COVID-19, a maioria apresentou doença ligeira e pode ser adequadamente seguida em ambulatório. Conclusão: Este estudo está de acordo com os poucos dados disponíveis na literatura e contribui para aumentar o conhecimento da infeção por SARS-CoV-2 em crianças com FQ. Essa informação permitirá uma melhor orientação destes doentes por parte das famílias e equipas clínicas que os seguem.Centro Hospitalar Universitário do Porto2022-10-19info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttps://doi.org/10.25753/BirthGrowthMJ.v31.i3.27540eng2183-9417Moreira, MafaldaSousa, PatríciaCatarino, SaraAzevedo, Inêsinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2022-10-20T17:00:18Zoai:ojs.revistas.rcaap.pt:article/27540Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:13:20.942125Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre Infeção por SARS-CoV-2 em crianças com fibrose quística: Experiência de um centro de referência português |
title |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
spellingShingle |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre Moreira, Mafalda Original Articles |
title_short |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
title_full |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
title_fullStr |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
title_full_unstemmed |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
title_sort |
SARS-CoV-2 infection in children with cystic fibrosis: Experience of a Portuguese reference centre |
author |
Moreira, Mafalda |
author_facet |
Moreira, Mafalda Sousa, Patrícia Catarino, Sara Azevedo, Inês |
author_role |
author |
author2 |
Sousa, Patrícia Catarino, Sara Azevedo, Inês |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Moreira, Mafalda Sousa, Patrícia Catarino, Sara Azevedo, Inês |
dc.subject.por.fl_str_mv |
Original Articles |
topic |
Original Articles |
description |
Introduction: Respiratory viruses are often responsible for pulmonary exacerbations and increased morbimortality in patients with cystic fibrosis (CF). For this reason, SARS-CoV-2 was expected to have a significant impact on the respiratory status of these patients, especially in those at risk. Detailed data of the clinical course of COVID-19 in children with CF is scarce. Objectives: The aim of this study was to determine the incidence, clinical characteristics, and course of COVID-19 infection in pediatric patients with CF. Material and methods: This was a retrospective observational study of children with CF and SARS-CoV-2 infection followed at a Portuguese reference centre between March 2020 and March 2022. Results: Twelve of 30 children with CF were infected by SARS-CoV-2 (40%), in a total of 13 episodes. The median age was 10.5 years, and 33% were male. Most cases (69%) occurred between January and March 2022, when Omicron was the predominant variant. The infection rate was higher in children not fully vaccinated. None of the children with additional risk factors was infected. Ninety-two percent of patients presented with mild disease and one child with low body mass index was hospitalized with pneumonia. None required oxygen therapy or admission to the Intensive Care Unit. No cases of mortality were reported. Eighty-three percent of patients fully recovered after two months of follow-up. Discussion: In this first national study of children with CF and COVID-19 infection, most children presented with mild disease and could be safely managed at home. Conclusion: This study is in line with the few evidence available in the literature and contributes to a better understanding of SARS-CoV-2 infection in children with CF during predominance of the Omicron variant, providing additional data that can guide families and clinical teams in the management of patients. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-19 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27540 |
url |
https://doi.org/10.25753/BirthGrowthMJ.v31.i3.27540 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
2183-9417 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.none.fl_str_mv |
Centro Hospitalar Universitário do Porto |
publisher.none.fl_str_mv |
Centro Hospitalar Universitário do Porto |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130587558051840 |